A historic medical accomplishment that ended in tragedy may yet have a silver lining.
The 62-year-old Slayman died just two months after he underwent the experimental procedure at Massachusetts General Hospital inApril 2024.
Early experiments using these organs have largely been performed onanimalsandpeopledeclared brain-dead.
© Angel Garcia/Bloomberg via Getty
Health regulators have begun allowing researchers to perform these experimental transplants on living patients who have few other options.
These procedures, groundbreaking as they are, have yet to yield a clear success story.
And this technology will continue to be tested more extensively in humans.
News from the future, delivered to your present.